• Home
  • OMGENE LIFE SCIENCES PRIVATE LIMITED

OMGENE LIFE SCIENCES PRIVATE LIMITED

  • Omgene Facility Makarpura, Vadodara, Gujarat INDIA
About OMGENE LIFE SCIENCES PRIVATE LIMITED

Omgene Life Sciences Pvt. Ltd., the R&D based Company, incorporated in March 2011 and is operating in Bio pharmaceutical space since it’s foundation. Omgene was established by a highly skilled and experienced pharmaceutical Technocrat, Dr. A.L. Prasad (Managing Director), having around 30 years of industrial track-record, is leading the R&D team comprising 100+ highly skilled workforce. Omgene is a fast-growing Indian company engaged in developing, manufacturing, and marketing of Peptide, Oligonucleotides, Semi-synthetic & Synthetic API and recombinant molecules.

Read more Show less
Certifications
  • GMP
    GMP
More certifications Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    India
  • On CPHI since:
    2020
  • Certificates:
    1
  • Employees:
    100 - 249
Company types
Pharmaceutical company
Primary activities
Generic APIs producer
Contact info
  • +91 90995 05299
  • 333/334, GIDC Makarpura,, Makarpura GIDC, Vadodara, 390010, Gujarat, India
Show contact info Hide contact info
Meet us at

CPHI Milan 2026

Fiera Milano, Italy
6 Oct 2026 - 8 Oct 2026
View Exhibitor Profile

Products from OMGENE LIFE SCIENCES PRIVATE LIMITED (45)

  • Complex Semi-synthetic APIs

    Product Complex Semi-synthetic APIs

    Micafungin Sodium, Anidulafungin-Fructose, Dalbavancin, Everolimus, Sarecycline, Midostaurin etc.
  • Omadacycline

    Product Omadacycline

    A tetracycline class antibacterial indicated for the treatment of adult patients with the following infections caused by susceptible microorganisms (1): Community-acquired bacterial pneumonia (CABP) (1.1); Acute bacterial skin and skin structure infections (ABSSSI) 
  • Rezafungin

    Product Rezafungin

    Rezafungin is a next-generation, semi-synthetic, cyclic lipopeptide and echinocandin derivative, with potential antifungal activity. 
  • Tirzepatide

    Product Tirzepatide

    Glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. 

  • Cetrorelix Acetate

    Product Cetrorelix Acetate

    Indicated for the inhibition of premature LH surges in women undergoing controlled ovarian stimulation.
  • Degarelix Acetate

    Product Degarelix Acetate

    Indicated for treatment of patients with advanced prostate cancer.
  • Apremilast

    Product Apremilast

    Indicated in Psoriatic Arthritis, Psoriasis and Oral Ulcers Associated with Behçet’s Disease
  • Bedaquiline Fumarate

    Product Bedaquiline Fumarate

    Diarylquinoline antimycobacterial drug indicated as part of combination therapy in the treatment of adult and pediatric patients (5 years and older and weighing at least 15 kg) with pulmonary multi-drug resistant tuberculosis (MDR-TB).
  • Binimetinib

    Product Binimetinib

    Indicated, in combination with encorafenib, for the treatment of patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation
  • Brivaracetam

    Product Brivaracetam

    Indicated for the treatment of partial-onset seizures in patients 4 years of age and older.
  • Carbetocin

    Product Carbetocin

    Used to prevent excessive bleeding after childbirth, particularly following Cesarean section.
  • Crisaborole

    Product Crisaborole

    Indicated for topical treatment of mild to moderate atopic dermatitis in adult and pediatric patients 3 months of age and older.
show all 45 products